ロード中...
Proteomic Analysis of Combined Gemcitabine and Birinapant in Pancreatic Cancer Cells
Pancreatic cancer is characterized by mutated signaling pathways and a high incidence of drug resistance. Comprehensive, large-scale proteomic analysis can provide a system-wide view of signaling networks, assist in understanding drug mechanisms of action and interactions, and serve as a useful tool...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2018-02-01
|
| シリーズ: | Frontiers in Pharmacology |
| 主題: | |
| オンライン･アクセス: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00084/full |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|